ExtraLife
Telomeres, telomerase, and the longevity frontier.
Every time your cells divide, the protective caps on your chromosomes — called telomeres — get slightly shorter. When telomeres become critically short, cells enter senescence (they stop dividing and begin to malfunction) or apoptosis (programmed death). This progressive shortening is one of the fundamental mechanisms of aging. Scientists have found that telomere length is a reliable biomarker for biological age, independent of chronological age.
Telomere shortening is a fundamental aging clock — shorter telomeres correlate with increased disease risk and accelerated biological aging.
Epithalon (Epitalon) is a synthetic version of epithalamine, a peptide naturally produced by the pineal gland. Its primary mechanism is telomerase activation — it stimulates the enzyme that rebuilds telomere length. Research by Professor Vladimir Khavinson and colleagues showed that Epithalon can extend telomeres in human cells in vitro and has been associated with increased lifespan in animal models. It also regulates melatonin production, supporting circadian rhythm and sleep quality. **Important Research Caveat**: The majority of Epithalon research originates from Professor Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology, and has been primarily published in Russian-language journals with limited Western peer review. The telomerase activation claims have not been independently replicated in large-scale Western clinical trials. While the body of preclinical work is substantial, the evidence base should be interpreted with this context in mind. **Research Status**: Limited/emerging evidence. Primarily from a single research group (Khavinson et al.), mostly published in Russian-language journals. In vitro telomerase activation demonstrated, but no independent large-scale Western clinical trials confirming longevity or lifespan benefits in humans. No FDA approval.
Epithalon activates telomerase in laboratory settings — but most research comes from a single group (Khavinson) with limited independent Western replication. Promising but requiring further validation.